SCHEMBL21532330

SCHEMBL21532330

CC(=O)N1c2ccc(-c3ccc(F)c(S(=O)(=O)C4CC4)c3)cc2N(C(=O)C2CC2)C[C@@H]1C

nearest known ligand 0.66

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 15/20 0.66
NPC1 O15118 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21532082 0.96 BRD4 (0.61) BRD4
SCHEMBL16722618 0.90 BRD4 (0.74) BRD4NPC1
SCHEMBL21675353 0.90 BRD4 (0.74) BRD4NPC1
SCHEMBL21675110 0.86 BRD4 (0.69) BRD4
SCHEMBL16721451 0.86 BRD4 (0.69) BRD4
SCHEMBL16721611 0.86 BRD4 (0.81) BRD4NPC1
SCHEMBL16722086 0.84 BRD4 (0.74) BRD4NPC1
SCHEMBL16721618 0.83 BRD4 (0.70) BRD4NPC1
SCHEMBL21674893 0.83 BRD4 (0.67) BRD4NPC1
SCHEMBL16722085 0.83 BRD4 (0.67) BRD4NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190330233-A1 BENZOPIPERAZINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS FORMA THERAPEUTICS, INC. 2019-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190330233-A1 BENZOPIPERAZINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS BRD4, BRPF3, BRD7 BRD4 1/4885NPC1 4000/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.